Chemours (CC) EBT (2014 - 2026)

Chemours' EBT history runs 13 years deep, the most recent figure standing at -$22.0 million for Q1 2026.

• In Q1 2026, EBT changed N/A year-over-year to -$22.0 million; the TTM figure through Mar 2026 stood at -$299.0 million (down 886.84% YoY), while the FY2025 annual figure was $176.0 million, up 66.04% from the prior year.
• EBT was -$22.0 million for Q1 2026 at Chemours, up from -$67.0 million in the prior quarter.
• In the past five years, EBT ranged from a high of $299.0 million in Q3 2022 to a low of -$433.0 million in Q2 2023.
• Historically, EBT has averaged $14.5 million across 5 years, with a median of $7.0 million in 2023.
• The sharpest annual moves came in 2022 and 2025: EBT surged 425.0% in 2022, then plunged 6800.0% in 2025.
• A 5-year view of EBT shows it stood at -$69.0 million in 2022, then declined by 2.9% to -$71.0 million in 2023, then surged by 101.41% to $1.0 million in 2024, then slumped by 6800.0% to -$67.0 million in 2025, then jumped by 67.16% to -$22.0 million in 2026.
• The last three EBT figures came in at -$22.0 million (Q1 2026), -$67.0 million (Q4 2025), and $38.0 million (Q3 2025), per Business Quant data.